Questions for Medicare in meningitis outbreak

The Boston Globe / Associated Press, October 23, 2012
Medicare is coming under scrutiny in the meningitis outbreak. The health insurance program for seniors long ago flagged compounded drugs produced for the mass market without oversight from the FDA as safety risks. Medicare doesn't seem to have consistently used its own legal power to deny payment, and critics say that has enabled the compounding business to flourish.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.